Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus: A prospective randomized multicentre study: The second Scandinavian trial in esophageal cancer
- 30 June 1992
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 24 (2) , 114-116
- https://doi.org/10.1016/0167-8140(92)90288-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancerWorld Journal of Surgery, 1992
- Perioperative multimodality management of esophageal cancer: Therapeutic or investigational?The Annals of Thoracic Surgery, 1990
- Survival and Esophageal Passage After Radiotherapy of Inoperable Esophageal Carcinoma: A Retrospective Study of 106 CasesActa Oncologica, 1990
- Cisplatin and bleomycin in the treatment of esophageal carcinoma: A final reportCancer, 1984
- Irradiation, chemotherapy and surgery in esophageal cancer: A randomized clinical studyRadiotherapy and Oncology, 1984
- Combined modality therapy of esophageal carcinomaCancer, 1981
- A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagusInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer. A randomized studyCancer, 1980
- Chemotherapy versus Chemoradiotherapy in Inoperable Esophageal CancerOncology, 1980
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataPublished by JSTOR ,1973